当前位置:首页 - 行情中心 - 复星医药(600196) - 财务分析 - 利润表

复星医药

(600196)

38.67

0.00  (0.00%)

今开:38.67最高:39.45成交:26.57万手 市盈:0.00 上证指数:3071.54   -1.47%2018-04-20
昨收:38.67 最低:37.93 换手:0.00%振幅:0.00 深证指数:10408.91  -1.79%15:31:01

集合

竞价

利润表

按照会计年度查询:
报告期2017-12-312017-09-302017-06-302017-03-31
一、营业总收入18,533,555,418.4212,959,812,919.478,353,022,551.943,880,454,791.54
营业收入18,533,555,418.4212,959,812,919.478,353,022,551.943,880,454,791.54
二、营业总成本16,988,959,633.6611,689,674,989.587,478,819,161.773,489,037,156.53
营业成本7,608,953,151.595,392,104,313.493,571,892,897.221,733,097,970.44
营业税金及附加222,924,252.39155,761,047.54104,849,790.4943,473,028.97
销售费用5,790,535,637.93,827,121,545.972,283,045,165.981,023,285,269.05
管理费用2,749,354,326.981,865,816,627.571,216,462,745.21553,116,423.82
财务费用554,784,714.43395,697,849.62251,048,310.3122,677,153.56
资产减值损失62,407,550.3753,173,605.3951,520,252.5713,387,310.69
三、其他经营收益-465,968,586.96-200,315,383.42-171,648,101.4324,377,519.08
允许价值变动净收益44,071,694.4311,965,468.94-3,561,625.78-158,141.41
投资净收益2,306,989,196.461,744,771,770.971,266,573,186.81548,741,983.64
联营、合营企业投资收益1,351,323,022.321,011,390,741.89754,378,948.97311,799,191.25
汇兑净收益--------
四、营业利润4,074,893,732.363,095,730,058.832,174,880,097.51940,001,477.24
营业外收入13,482,523.0548,825,578.4214,885,095.6319,104,135.25
营业外支出26,659,731.7127,679,059.410,601,224.275,724,555.13
非流动资产处置净损失--8,885,987.973,422,6201,717,264.6
五、利润总额4,061,716,523.73,116,876,577.852,179,163,968.87953,381,057.36
所得税476,457,580.05359,534,518.87252,544,986.67117,416,637.53
未确认的投资损失--------
六、净利润(百万元)3,124.52,419.271,689.06737.75
少数股东损益460,759,394.3338,075,114.17237,559,327.3198,217,737.22
归属于母公司股东的净利润3,124,499,549.352,419,266,944.811,689,059,654.89737,746,682.61
七、每股收益1.270.990.70.32
基本每股收益1.270.990.70.32
稀释每股收益1.270.990.70.31
TOP↑